Paper39770554
ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B.
Fattouche M and 8 others. Pharmaceuticals (Basel), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Papers, record 39770554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39770554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NOT AVAILABLE | American University of the Middle East | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35352175 | Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies. | J Mol Model | 2022 | https://conductscience.org/library/papers/35352175 | PubMed |
| 2 | 28256516 | SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. | Sci Rep | 2017 | https://conductscience.org/library/papers/28256516 | PubMed |
| 3 | 23299630 | Some case studies on application of "r(m)2" metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response data. | J Comput Chem | 2013 | https://conductscience.org/library/papers/23299630 | PubMed |
| 4 | 32964807 | Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/32964807 | PubMed |
| 5 | 10746014 | A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. | J Comb Chem | 1999 | https://conductscience.org/library/papers/10746014 | PubMed |
| 6 | 19709881 | Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides. | Bioorg Med Chem Lett | 2009 | https://conductscience.org/library/papers/19709881 | PubMed |
| 7 | 11858635 | Beware of q2! | J Mol Graph Model | 2002 | https://conductscience.org/library/papers/11858635 | PubMed |
| 8 | 17599350 | Predicting absolute ligand binding free energies to a simple model site. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17599350 | PubMed |
| 9 | 12036371 | Molecular properties that influence the oral bioavailability of drug candidates. | J Med Chem | 2002 | https://conductscience.org/library/papers/12036371 | PubMed |
| 10 | 9504803 | SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. | Electrophoresis | 1997 | https://conductscience.org/library/papers/9504803 | PubMed |
| 11 | 34918764 | QSAR Studies and Structure Property/Activity Relationships Applied in Pyrazine Derivatives as Antiproliferative Agents Against the BGC823. | Acta Chim Slov | 2021 | https://conductscience.org/library/papers/34918764 | PubMed |
| 12 | 19399780 | AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19399780 | PubMed |
| 13 | 28273884 | 2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity. | Molecules | 2017 | https://conductscience.org/library/papers/28273884 | PubMed |
| 14 | 17049853 | Isothiazoles as active-site inhibitors of HCV NS5B polymerase. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17049853 | PubMed |
| 15 | 11259830 | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11259830 | PubMed |
| 16 | 33558778 | QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods. | Chemometr Intell Lab Syst | 2021 | https://conductscience.org/library/papers/33558778 | PubMed |
| 17 | 27463326 | Best Practices for QSAR Model Development, Validation, and Exploitation. | Mol Inform | 2010 | https://conductscience.org/library/papers/27463326 | PubMed |
| 18 | 27108770 | Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power. | Phys Chem Chem Phys | 2016 | https://conductscience.org/library/papers/27108770 | PubMed |
| 19 | 36947906 | Parsing structural fragments of thiazolidin-4-one based α-amylase inhibitors: A combined approach employing in vitro colorimetric screening and GA-MLR based QSAR modelling supported by molecular docking, molecular dynamics simulation and ADMET studies. | Comput Biol Med | 2023 | https://conductscience.org/library/papers/36947906 | PubMed |
| 20 | 37966948 | Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates for the SARS-CoV-2 inhibitors. | Nat Prod Res | 2024 | https://conductscience.org/library/papers/37966948 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42280532 | Machine Learning-Based Prediction of Polymer Properties Using Structure-Property Relationship Modeling. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42280532 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39770554
GET https://conductscience.org/api/papers/v1/39770554/references?page=2